Sign In
Buy PBLA
$0.0050
-0.0061 (-54.95%)
At Close: Jun 22, 2026
Panbela Therapeutics Earnings Calls
Mar 31, 2026
(Upcoming)
| Release date | Aug 12, 2026 |
| EPS estimate | -$2,640.00 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 12.68% |
Dec 31, 2025
| Release date | Mar 25, 2026 |
| EPS estimate | -$2,640.00 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Sep 30, 2025
| Release date | Nov 12, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Jun 30, 2025
| Release date | Jul 23, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Panbela Therapeutics
Below you can see how PBLA performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Jun 30, 2025
| Release date | Jul 23, 2025 |
| Price on release | $0.158 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 17, 2025 | $0.186 |
| Jul 18, 2025 | $0.190 |
| Jul 21, 2025 | $0.158 |
| Jul 22, 2025 | $0.158 |
| Jul 23, 2025 | $0.158 |
| Jul 24, 2025 | $0.158 |
| Jul 25, 2025 | $0.158 |
| Jul 28, 2025 | $0.158 |
| Jul 29, 2025 | $0.158 |
| 4 days before | -15.11% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -15.11% |
Sep 30, 2025
| Release date | Nov 12, 2025 |
| Price on release | $0.0111 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 06, 2025 | $0.0200 |
| Nov 07, 2025 | $0.0200 |
| Nov 10, 2025 | $0.0200 |
| Nov 11, 2025 | $0.0200 |
| Nov 12, 2025 | $0.0111 |
| Nov 13, 2025 | $0.0111 |
| Nov 14, 2025 | $0.0111 |
| Nov 17, 2025 | $0.0111 |
| Nov 18, 2025 | $0.0111 |
| 4 days before | -44.50% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -44.50% |
Dec 31, 2025
| Release date | Mar 25, 2026 |
| Price on release | $0.0002 |
| EPS estimate | -$2,640.00 |
| EPS actual | - |
| Date | Price |
|---|---|
| Mar 19, 2026 | $0.0002 |
| Mar 20, 2026 | $0.0002 |
| Mar 23, 2026 | $0.0002 |
| Mar 24, 2026 | $0.0002 |
| Mar 25, 2026 | $0.0002 |
| Mar 26, 2026 | $0.0002 |
| Mar 27, 2026 | $0.0002 |
| Mar 30, 2026 | $0.0002 |
| Mar 31, 2026 | $0.0002 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Mar 31, 2026
(Upcoming)
| Release date | Aug 12, 2026 |
| Price on release | - |
| EPS estimate | -$2,640.00 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 15, 2026 | $0.0111 |
| Jun 16, 2026 | $0.0111 |
| Jun 17, 2026 | $0.0111 |
| Jun 18, 2026 | $0.0111 |
| Jun 22, 2026 | $0.0050 |
Panbela Therapeutics Earnings History
Earnings Calendar
FAQ
When is the earnings report for PBLA?
Panbela Therapeutics Inc. (PBLA) has scheduled its earnings report for Aug 12, 2026 after the markets close.
What is the PBLA price-to-earnings (P/E) ratio?
PBLA P/E ratio as of Jun 22, 2026 (TTM) is -0.0014.
What is the PBLA EPS forecast?
The forecasted EPS (Earnings Per Share) for Panbela Therapeutics Inc. (PBLA) for the first fiscal quarter 2026 is -$2,640.00.
What are Panbela Therapeutics Inc.'s retained earnings?
On its balance sheet, Panbela Therapeutics Inc. reported retained earnings of $0 for the latest quarter ending Dec 31, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
